Withdrawal of Allopurinol in Patients with Gout

  • J. T. Scott
  • W. Y. Loebl
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 41 B)

Abstract

A few years ago the possibility was raised that allopurinol therapy might lead to the incorporation of abnormal genetic material into cell nuclei. Another potential hazard was suggested by the finding of crystals of allopurinol and oxypurinol in muscle biopsy specimens from patients taking allopurinol. It subsequently appears that the first eventuality does not in fact occur and that the second is of no clinical significance. At the time, however, it was thought to be reasonable to determine the effect of discontinuing allopurinol therapy in gout patients who were not over-producers of uric acid and whose renal function was not impaired.

Keywords

Renal Function Uric Acid Potential Hazard Gouty Arthritis Purine Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer Science+Business Media New York 1974

Authors and Affiliations

  • J. T. Scott
    • 1
  • W. Y. Loebl
    • 1
  1. 1.Charing Cross Hospital and Kennedy Institute of RheumatologyLondonUK

Personalised recommendations